23 results for author:"Williams G.T." in Literature citations
Results Customize
› Repeat search in UniProtKB (7)
| Candidate tumour suppressor Fau regulates apoptosis in human cells: an essential role for Bcl-G. Pickard M.R., Mourtada-Maarabouni M., Williams G.T. Biochim. Biophys. Acta 1812:1146-1153(2011) · Mapped (2) |
| Phosphoinositide 3-kinase gamma mediates chemotactic responses of human eosinophils to platelet-activating factor. Hasan A.M., Mourtada-Maarabouni M., Hameed M.S., Williams G.T., Dent G. Int. Immunopharmacol. 10:1017-1021(2010) · Mapped (3) |
| FAU regulates carboplatin resistance in ovarian cancer. Moss E.L., Mourtada-Maarabouni M., Pickard M.R., Redman C.W., Williams G.T. Genes Chromosomes Cancer 49:70-77(2010) · Mapped (2) |
| The APC Variant p.Glu1317Gln predisposes to colorectal adenomas by a novel mechanism of relaxing the target for tumorigenic somatic APC mutations. Dallosso A.R., Jones S., Azzopardi D., Moskvina V., Al-Tassan N., Williams G.T., Idziaszczyk S., Davies D.R., Milewski P., Williams S. et al. Hum. Mutat. 30:1412-1418(2009) · Mapped (10) |
| Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer. Pickard M.R., Green A.R., Ellis I.O., Caldas C., Hedge V.L., Mourtada-Maarabouni M., Williams G.T. Breast Cancer Res. 11:R60-R60(2009) · UniProtKB (1) · Mapped (10) |
| Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation. Marsh V., Winton D.J., Williams G.T., Dubois N., Trumpp A., Sansom O.J., Clarke A.R. Nat. Genet. 40:1436-1444(2008) · Mapped (16) |
| Characterisation of cDNAs of key genes involved in apoptosis in common carp (Cyprinus carpio L.). Cols Vidal M., Hoole D., Williams G.T. Fish Shellfish Immunol. 25:494-507(2008) · UniProtKB (2) |
| Dependence of antibody gene diversification on uracil excision. Di Noia J.M., Williams G.T., Chan D.T., Buerstedde J.M., Baldwin G.S., Neuberger M.S. J. Exp. Med. 204:3209-3219(2007) · Mapped (4) |
| Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes. Mourtada-Maarabouni M., Keen J., Clark J., Cooper C.S., Williams G.T. Exp. Cell Res. 312:1745-1752(2006) · Mapped (3) |
| Regulation of apoptosis by fau revealed by functional expression cloning and antisense expression. Mourtada-Maarabouni M., Kirkham L., Farzaneh F., Williams G.T. Oncogene 23:9419-9426(2004) · Mapped (2) |
| Functional expression cloning reveals proapoptotic role for protein phosphatase 4. Mourtada-Maarabouni M., Kirkham L., Jenkins B., Rayner J., Gonda T.J., Starr R., Trayner I., Farzaneh F., Williams G.T. Cell Death Differ. 10:1016-1024(2003) · UniProtKB (1) |
| Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta-6 of the candidate tumour suppressor LUCA-15/RBM5. Mourtada-Maarabouni M., Sutherland L.C., Meredith J.M., Williams G.T. |
| Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., Neuberger M.S. Curr. Biol. 12:1748-1755(2002) · Mapped (4) |
| Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations. Jones S., Emmerson P., Maynard J., Best J.M., Jordan S., Williams G.T., Sampson J.R., Cheadle J.P. Hum. Mol. Genet. 11:2961-2967(2002) · Mapped (13) |
| Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways. Mourtada-Maarabouni M., Sutherland L.C., Williams G.T. Apoptosis 7:421-432(2002) · UniProtKB (1) |
| Complete cDNA sequence of SAP-like pentraxin from Limulus polyphemus: implications for pentraxin evolution. Tharia H.A., Shrive A.K., Mills J.D., Arme C., Williams G.T., Greenhough T.J. J. Mol. Biol. 316:583-597(2002) · UniProtKB (1) |
| Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Al-Tassan N., Chmiel N.H., Maynard J., Fleming N., Livingston A.L., Williams G.T., Hodges A.K., Davies D.R., David S.S., Sampson J.R. et al. |
| LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Sutherland L.C., Edwards S.E., Cable H.C., Poirier G.G., Miller B.A., Cooper C.S., Williams G.T. Oncogene 19:3774-3781(2000) · UniProtKB (1) |
| Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. O'Keefe T.L., Williams G.T., Batista F.D., Neuberger M.S. J. Exp. Med. 189:1307-1313(1999) · Mapped (7) |
| Mice carrying a CD20 gene disruption. O'Keefe T.L., Williams G.T., Davies S.L., Neuberger M.S. Immunogenetics 48:125-132(1998) · Mapped (3) |
| Hyperresponsive B cells in CD22-deficient mice. O'Keefe T.L., Williams G.T., Davies S.L., Neuberger M.S. Science 274:798-801(1996) · Mapped (10) |
| Developmental regulation of bcl-2 expression in the thymus. Moore N.C., Anderson G., Williams G.T., Owen J.J., Jenkinson E.J. Immunology 81:115-119(1994) · Mapped (3) |
| Yeast DNA primase and DNA polymerase activities. An analysis of RNA priming and its coupling to DNA synthesis. Singh H., Brooke R.G., Pausch M.H., Williams G.T., Trainor C., Dumas L.B. J. Biol. Chem. 261:8564-8569(1986) · Mapped (2) |